Annual Drug Patent Expirations for PATANASE
Patanase is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for PATANASE.
The generic ingredient in PATANASE is olopatadine hydrochloride. Two suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
